SEARCH

SEARCH BY CITATION

References

  • 1
    Lee Williams R. Hyperbaric oxygen therapy and the diabetic foot. J Am Podiatr Med Assoc 1997; 87(6): 279292.
  • 2
    Berendt AR. Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis 2006; 43(2): 193198.
  • 3
    Hinchliffe RJ et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008; 24(Suppl 1): S119S144.
  • 4
    Abidia A et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 2003; 25(6): 513518.
  • 5
    Londahl M et al. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33(5): 9981003.
  • 6
    Londahl M, Landin-Olsson M, Katzman P. Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabet Med 2011; 28(2): 186190.
  • 7
    Hammarlund C. Hyperbaric oxygenation and wound repair in man. In Anesthesiology and Intensive Care. Lund: Lund, 1995.
  • 8
    Warriner RA HH. Enhancement of healing in selected problem wounds. In The Hyperbaric Oxygen Committee Report, Feldmeier J (ed). Undersea and Hyperbaric Medical Society, Inc: Kensington, Maryland, 2003; 4155.
  • 9
    Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334(25): 16421648.
  • 10
    Hunt TK, Hopf HW. Wound healing and wound infection. What surgeons and anesthesiologists can do. Surg Clin North Am 1997; 77(3): 587606.
  • 11
    Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 1919; 52(6): 409415.
  • 12
    Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90(2): 262270.
  • 13
    Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972; 135(4): 561567.
  • 14
    Hunt TK et al. The effect of differing ambient oxygen tensions on wound infection. Ann Surg 1975; 181(1): 3539.
  • 15
    Allen DB et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997; 132(9): 991996.
  • 16
    Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 1986; 121(2): 191195.
  • 17
    Mandell GL. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 1974; 9(2): 337341.
  • 18
    Mader JT et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 1980; 142(6): 915922.
  • 19
    Babior BM. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med 1978; 298(13): 721725.
  • 20
    Babior BM. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med 1978; 298(12): 659668.
  • 21
    Hind J, Attwell RW. The effect of antibiotics on bacteria under hyperbaric conditions. J Antimicrob Chemother 1996; 37(2): 253263.
  • 22
    Kent TA et al. Effect of hyperbaric oxygen on the blood: cerebrospinal fluid transfer of tobramycin. Aviat Space Environ Med 1986; 57(7): 664666.
  • 23
    Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6(4): 389395.
  • 24
    Hattori K et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193(9): 10051014.
  • 25
    Sheikh AY et al. Hyperoxia improves microvascular perfusion in a murine wound model. Wound Repair Regen 2005; 13(3): 303308.
  • 26
    Sheikh AY et al. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg 2000; 135(11): 12931297.
  • 27
    Gallagher KA et al. Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular 2006; 14(6): 328337.
  • 28
    Milovanova TN et al. Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1. Mol Cell Biol 2008; 28(20): 62486261.
  • 29
    Hunt TK et al. Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid Redox Signal 2007; 9(8): 11151124.
  • 30
    Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 2009; 106(3): 988995.
  • 31
    Dinar S et al. Effects of hyperbaric oxygen therapy on fibrovascular ingrowth in porous polyethylene blocks implanted under burn scar tissue: an experimental study. Burns 2008; 34(4): 467473.
  • 32
    Hopf HW et al. Hyperoxia and angiogenesis. Wound Repair Regen 2005; 13(6): 558564.
  • 33
    Du X et al. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 2006; 116(4): 10711080.
  • 34
    Bucci M et al. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscler Thromb Vasc Biol 2004; 24(4): 721726.
  • 35
    Thom SR et al. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 2006; 290(4): H1378H1386.
  • 36
    Wattel F et al. Acute peripheral ischaemia and compartment syndromes: a role for hyperbaric oxygenation. Anaesthesia 1998; 53(Suppl 2): 6365.
  • 37
    Hussain MZ, Ghani QP, Hunt TK. Inhibition of prolyl hydroxylase by poly(ADP-ribose) and phosphoribosyl-AMP. Possible role of ADP-ribosylation in intracellular prolyl hydroxylase regulation. J Biol Chem 1989; 264(14): 78507855.
  • 38
    Hartmann M, Jonsson K, Zederfeldt B. Effect of tissue perfusion and oxygenation on accumulation of collagen in healing wounds. Randomized study in patients after major abdominal operations. Eur J Surg 1992; 158(10): 521526.
  • 39
    Londahl M, Fagher K, Katzman P. What is the role of hyperbaric oxygen in the management of diabetic foot disease? Curr Diab Rep 2011; 11(4): 285293.
  • 40
    Plafki C et al. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 2000; 71(2): 119124.
  • 41
    Sheffield PJ, Smith AP. Physiological and pharmacological basis of hyperbaric oxygen therapy. In Hyperbaric Surgery, Bakker D, Cramer F (ed). Best Publishing Company: Flaggstaff, AZ, USA, 2002; 63109.
  • 42
    Murphy DG et al. Tension pneumothorax associated with hyperbaric oxygen therapy. Am J Emerg Med 1991; 9(2): 176179.
  • 43
    Trytko BE, Bennett M. Hyperbaric oxygen therapy. Complication rates are much lower than author suggest. BMJ 1999; 318(7190): 10771078.
  • 44
    Heyneman CA, Lawless-Liday C. Using hyperbaric oxygen to treat diabetic foot ulcers: safety and effectiveness. Crit Care Nurse 2002; 22(6): 5260.
  • 45
    Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 1984; 68(2): 113117.
  • 46
    Broussard CL. Hyperbaric oxygenation and wound healing. J Vasc Nurs 2004; 22(2): 4248.
  • 47
    Sheffield PJ, Desautels DA. Hyperbaric and hypobaric chamber fires: a 73-year analysis. Undersea Hyperb Med 1997; 24(3): 153164.
  • 48
    Hart G, Strauss M. Response of ischemic ulcerative conditions to OHP. In Sixth International Congress on Hyperbaric Medicine. Aberdeen University Press: Aberdeen, 1979.
  • 49
    Baroni G et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 1987; 10(1): 8186.
  • 50
    Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med 1992; 38(3): 112114, 111.
  • 51
    Wunderlich RP, Peters EJ, Lavery LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care 2000; 23(10): 15511555.
  • 52
    Roeckl-Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 2005; 92(1): 2432.
  • 53
    Kranke P et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004; (2): CD004123.
  • 54
    Goldman RJ. Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review. PM R 2009; 1(5): 471489.
  • 55
    Wang C, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 2003; 138(3): 272279; discussion 280.
  • 56
    Faglia E et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996; 19(12): 13381343.
  • 57
    Kessler L et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 2003; 26(8): 23782382.
  • 58
    Duzgun AP et al. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg 2008; 47(6): 515519.
  • 59
    Oriani G, Meazza D, Favales F. Hyperbaric oxygen therapy in diabetic gangrene. J Hyperb Med 1990; 5(3): 171175.
  • 60
    Zamboni WA et al. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 1993; 91(6): 11101123.
  • 61
    Kalani M et al. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications 2002; 16(2): 153158.
  • 62
    Lin LC et al. The efficacy of hyperbaric oxygen therapy in improving the quality of life in patients with problem wounds. J Nurs Res 2006; 14(3): 219227.
  • 63
    Lipsky BA, Berendt AR. Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype? Diabetes Care 2010; 33(5): 11431145.
  • 64
    Chuck AW et al. Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. Int J Technol Assess Health Care 2008; 24(2): 178183.
  • 65
    Londahl M et al. Response to comment on: Londahl et al. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010;33:998–1003. Diabetes Care 2011; 34(6): e112.
  • 66
    Matos L. Preliminary report of the use of hyperbarics as adjunctive therapy in diabetics with chronic non-healing wounds. HBO Review 1983; 4(2): 8889.
  • 67
    Perrins J, Barr P. Hyperbaric oxygen and wound healing. In First Swiss symposium on Hyperbaric Medicine. Foundation for Hyperbaric Medicine: Basel, 1986.
  • 68
    Davis JC. The use of adjuvant hyperbaric oxygen in treatment of the diabetic foot. Clin Podiatr Med Surg 1987; 4(2): 429437.
  • 69
    Wattel F et al. Hyperbaric oxygen therapy in chronic vascular wound management. Angiology 1990; 41(1): 5965.
  • 70
    Cianci P, Petrone G, Green B. Adjunctive hyperbaric oxygen in salvage of the diabetic foot. Undersea Biomed Res 1991; 18(suppl): 108.
  • 71
    Weisz G, Ramon Y, Melamed T. Treatment of the diabetic foot by hyperbaric oxygen. Harefuah 1993; 124: 678681.
  • 72
    Ciaravino ME, Friedell ML, Kammerlocher TC. Is hyperbaric oxygen a useful adjunct in the management of problem lower extremity wounds? Ann Vasc Surg 1996; 10(6): 558562.
  • 73
    Lee S et al. Hyperbaric oxygen in the treatment of diabetic foot infection. Changgeng Yi Xue Za Zhi 1997; 20(1): 1722.
  • 74
    Zambroni W et al. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb Med 1997; 24(3): 175179.